ReShape Lifesciences Inc. Signs Material Definitive Agreement
Ticker: HIND · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, definitive-agreement
TL;DR
RESH just signed a big deal, details TBD.
AI Summary
On April 25, 2025, ReShape Lifesciences Inc. entered into a material definitive agreement. The filing does not provide specific details on the agreement's nature or any associated dollar amounts. The company is incorporated in Delaware and its principal executive offices are located in Irvine, California.
Why It Matters
This filing indicates a significant new agreement for ReShape Lifesciences, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing regarding the material definitive agreement introduces uncertainty about its implications.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- April 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Irvine, CA (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by ReShape Lifesciences Inc. on April 25, 2025?
The filing states that ReShape Lifesciences Inc. entered into a material definitive agreement on April 25, 2025, but does not provide specific details about its nature.
Are there any financial terms or dollar amounts associated with this material definitive agreement?
The provided filing does not disclose any specific dollar amounts or financial terms related to the material definitive agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 25, 2025.
In which state is ReShape Lifesciences Inc. incorporated?
ReShape Lifesciences Inc. is incorporated in Delaware.
What is the address of ReShape Lifesciences Inc.'s principal executive offices?
The principal executive offices of ReShape Lifesciences Inc. are located at 18 Technology Drive, Suite 110, Irvine, CA 92618.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding ReShape Lifesciences Inc. (HIND).